1-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Hematology
Top 10s
Hematology
Current Top 10 by F1000 Factor
All Time Top 10 by F1000 Factor
Most viewed Top 10
(from all journals)
Most viewed Top 10
(from specialty journals)
Hidden Jewels
Sections Covered
Anemias & Hypocellular Marrow Disorders
Bleeding & Coagulation Disorders
Hematologic Transplantation & Transfusion
Hematopoietic Stem Cells
Leukemia & Proliferative Disorders of Hematic Cells
Lymphomas & Myelomas
Non-hematopoietic Stem Cells
Pediatric Hematology
Related Sections
Perioperative Hemostasis & Transfusion Medicine
MOST VIEWED TOP 10 (from specialty journals) | Hematology | calculated on 1 December 2008
The "Most Viewed Top 10 (from specialty journals)" Top 10 lists are generated every day and comprise only articles published in specialty journals. The articles are ordered by the number of times an article's evaluation(s) has/have been viewed over the past 30 days. The general journals that are excluded from this list are;
Ama Arch Intern Med, Ann Intern Med, BMJ, Cell, CMAJ, J Clin Invest, JAMA, Lancet, N Engl J Med, Nat Med, Nature, Science.
browse faculty
| show Most Viewed (specialty journals) Papers in
ALL OF MEDICINE
Anesthesiology & Pain Management
Cardiovascular Disorders
Critical Care & Emergency Medicine
Dermatology
Diabetes & Endocrinology
Gastroenterology & Hepatology
Hematology
Infectious Diseases
Nephrology
Neurological Disorders
Oncology
Psychiatry
Public Health & Epidemiology
Research Methodology
Respiratory Disorders
Rheumatology & Clinical Immunology
Urology
Women's Health
selected articles
all 10 items
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
1
Exceptional
F1000 Factor
9.0
Confirmation
New Finding
Tech Advance
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages.
Xia W, Hilgenbrink AR, …, Cheng JX, Low PS
Blood
2008 Oct 24 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Asok Antony
Evaluated 13 Nov 2008
2
Must Read
F1000 Factor
4.8
New Finding
Tech Advance
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Wiernik PH, Lossos IS, …, Zeldis JB, Habermann TM
J Clin Oncol
2008 Oct 20
26
(30):4952-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Asher Chanan-Khan with Sikander Ailawadhi / Allessandro Gianni with Michele Magni
First evaluation 7 Nov 2008 | Latest evaluation 19 Nov 2008
3
Must Read
F1000 Factor
6.0
Hypothesis
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.
Taussig DC, Miraki-Moud F, …, Gribben JG, Bonnet D
Blood
2008 Aug 1
112
(3):568-75 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Zhu Chen
Evaluated 25 Sep 2008
4
Must Read
F1000 Factor
4.8
Confirmation
New Finding
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
Robinson KS, Williams ME, …, Lemieux B, Cheson BD
J Clin Oncol
2008 Sep 20
26
(27):4473-9 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Kensei Tobinai / Allessandro Gianni with Michele Magni
First evaluation 24 Sep 2008 | Latest evaluation 21 Oct 2008
5
Recommended
F1000 Factor
3.0
Confirmation
New Finding
Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
Goodman KA, Riedel E, …, Moskowitz CH, Yahalom J
J Clin Oncol
2008 Nov 10
26
(32):5240-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Andreas Engert with Nicole Skoetz
Evaluated 12 Nov 2008
6
Exceptional
F1000 Factor
9.0
Hypothesis
New Finding
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.
Frassoni F, Gualandi F, …, Labopin M, Bacigalupo A
Lancet Oncol
2008 Sep
9
(9):831-9 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Bruce Camitta with Julie Talano
Evaluated 17 Sep 2008
7
Must Read
F1000 Factor
6.0
Confirmation
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.
Salles G, Mounier N, …, Xerri L, Foussard C
Blood
2008 Sep 17 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Armando López-Guillermo
Evaluated 20 Nov 2008
8
Must Read
F1000 Factor
4.8
Confirmation
Tech Advance
Controversial
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Sorror ML, Storer BE, …, Storb R, Maloney DG
J Clin Oncol
2008 Oct 20
26
(30):4912-20 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Arnon Nagler / Francesco Onida with Giorgia Saporiti
First evaluation 22 Sep 2008 | Latest evaluation 31 Oct 2008
9
Recommended
F1000 Factor
3.0
New Finding
Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche.
Jung Y, Song J, …, Krebsbach PH, Taichman RS
Stem Cells
2008 Aug
26
(8):2042-51 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Hector Mayani
Evaluated 6 Nov 2008
10
Recommended
F1000 Factor
3.0
Changes
Clinical Practice
Tech Advance
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.
Tefferi A, Vardiman JW
Leukemia
2008 Jan
22
(1):14-22 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Richard Larson with Olatoyosi Odenike
Evaluated 5 Feb 2008
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info
Confirmation
New Finding
Tech Advance
Hypothesis
Controversial